The Biology and Clinical Development of MEK Inhibitors for Cancer Jason J. LukePatrick A. OttGeoffrey I. Shapiro Leading Article 21 November 2014 Pages: 2111 - 2128
Intensive Intervention Can Lead to a Treatment Holiday from Biological DMARDs in Patients with Rheumatoid Arthritis Yoshiya TanakaShintaro Hirata Leading Article Open access 12 November 2014 Pages: 2129 - 2139
Combining a GLP-1 Receptor Agonist and Basal Insulin: Study Evidence and Practical Considerations Nicholas W. CarrisJames R. TaylorJohn G. Gums Therapy in Practice 21 November 2014 Pages: 2141 - 2152
Rifaximin: A Review of Its Use in Reducing Recurrence of Overt Hepatic Encephalopathy Episodes Lesley J. Scott Adis Drug Evaluation 29 October 2014 Pages: 2153 - 2160
Liraglutide: A Review of Its Use in Adult Patients with Type 2 Diabetes Mellitus Lesley J. Scott Adis Drug Evaluation 04 November 2014 Pages: 2161 - 2174
Pramipexole Extended-Release: A Review of Its Use in Patients with Parkinson’s Disease James E. Frampton Adis Drug Evaluation 11 November 2014 Pages: 2175 - 2190
Dapagliflozin: A Review of Its Use in Patients with Type 2 Diabetes Greg L. Plosker Adis Drug Evaluation 12 November 2014 Pages: 2191 - 2209
Ripasudil: First Global Approval Karly P. Garnock-Jones R&D Insight Report 21 November 2014 Pages: 2211 - 2215
Erratum to: New Directions for Rabbit Antithymocyte Globulin (Thymoglobulin®) in Solid Organ Transplants, Stem Cell Transplants and Autoimmunity Mohamad MohtyAndrea BacigalupoYvon Lebranchu Erratum 25 November 2014 Pages: 2217 - 2217